[Hereditary leiomyomatosis syndrome associated with renal cell carcinoma. A case report]

Rev Esp Patol. 2021 Jul-Sep;54(3):193-196. doi: 10.1016/j.patol.2019.07.001. Epub 2019 Aug 22.
[Article in Spanish]

Abstract

Hereditary leiomyomatosis (HL) is a rare autosomal dominant syndrome resulting from a mutation in the germline of the fumarate hydratase (FH) gene. Patients with this syndrome have an increased risk of cutaneous and uterine smooth muscle tumors as well as renal cancer. Renal carcinoma associated with hereditary leiomyomatosis (HLRCC) was recognized as a subtype of independent renal tumor in the 2016 WHO classification. We present a case of HLRCC occurring in a 39-year-old man with no family history or specific skin manifestations at the time of diagnosis.

Keywords: Carcinoma de células renales deficiente en fumarato hidratasa; Fumarate hydratase; Fumarate hydratase-deficient renal cell carcinoma; Fumarato hidratasa; Hereditary leiomyomatosis and renal cell carcinoma syndrome; Leiomiomatosis hereditaria asociada a carcinoma de células renales.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Carcinoma, Renal Cell / chemistry
  • Carcinoma, Renal Cell / genetics
  • Carcinoma, Renal Cell / pathology*
  • Humans
  • Kidney Neoplasms / chemistry
  • Kidney Neoplasms / genetics
  • Kidney Neoplasms / pathology*
  • Leiomyomatosis / chemistry
  • Leiomyomatosis / genetics
  • Leiomyomatosis / pathology*
  • Male
  • Neoplastic Syndromes, Hereditary / genetics
  • Neoplastic Syndromes, Hereditary / pathology*
  • Skin Neoplasms / chemistry
  • Skin Neoplasms / genetics
  • Skin Neoplasms / pathology*
  • Uterine Neoplasms / chemistry
  • Uterine Neoplasms / genetics
  • Uterine Neoplasms / pathology*

Supplementary concepts

  • Hereditary leiomyomatosis and renal cell cancer